APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spine Biologics

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.

Selected research

Industry Growth & Trends

Global Spine Biologics Industry Growth and Trends Forecast to 2032

23 December 2025107 pages

Choose your research edition.

Industry ResearchSpine Biologics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Spine Biologics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Spine Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spine Biologics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Spine Biologics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.

Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%.

North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%.

Read the full market overview

In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc.

Report Scope

This report provides a structured, data-driven view of the global Spine Biologics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Spine Biologics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Spine Biologics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Spine Biologics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Spine Biologics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Spine Biologics Market by Company

Medtronic

Depuy Synthes

Stryker Corporation

Nuvasive

Zimmer Biomet

Orthofix International

Globus Medical

alphatec spine

K2M

Exactech

Wright Medical Technology

X-Spine

Nutech

Arthrex

Spine Biologics Segment by Type

Bone Graft

Bone Graft Substitute

Platelet Rich Plasma (PRP)

BMAC (Bone Marrow Aspirate Concentrate)

Spine Biologics Segment by Application

Anterior Cervical Discectomy and Fusion

Posterior Lumbar Interbody Fusion

Others

Spine Biologics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spine Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spine Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spine Biologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Spine Biologics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Spine Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bone Graft Table 2. Major Company of Bone Graft Substitute Table 3. Major Company of Platelet Rich Plasma (PRP) Table 4. Major Company of BMAC (Bone Marrow Aspirate Concentrate) Table 5. Global Spine Biologics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Spine Biologics Sales by Type (2021-2026) & (K Units) Table 7. Global Spine Biologics Sales Market Share in Volume by Type (2021-2026) Table 8. Global Spine Biologics Sales by Type (2021-2026) & (US$ Million) Table 9. Global Spine Biologics Sales Market Share in Value by Type (2021-2026) Table 10. Global Spine Biologics Price by Type (2021-2026) & (USD/Unit) Table 11. Global Spine Biologics Sales by Type (2027-2032) & (K Units) Table 12. Global Spine Biologics Sales Market Share in Volume by Type (2027-2032) Table 13. Global Spine Biologics Sales by Type (2027-2032) & (US$ Million) Table 14. Global Spine Biologics Sales Market Share in Value by Type (2027-2032) Table 15. Global Spine Biologics Price by Type (2027-2032) & (USD/Unit) Table 16. North America Spine Biologics Sales by Type (2021-2026) & (K Units) Table 17. North America Spine Biologics Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Spine Biologics Sales by Type (2021-2026) & (K Units) Table 19. Europe Spine Biologics Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Spine Biologics Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Spine Biologics Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Spine Biologics Sales by Type (2021-2026) & (K Units) Table 23. Latin America Spine Biologics Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Spine Biologics Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Spine Biologics Sales by Type (2021-2026) & (US$ Million) Table 26. Spine Biologics Industry Trends Table 27. Spine Biologics Industry Drivers Table 28. Spine Biologics Industry Opportunities and Challenges Table 29. Spine Biologics Industry Restraints Table 30. Global Spine Biologics Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Spine Biologics Revenue Market Share by Company (2021-2026) Table 32. Global Spine Biologics Sales by Company (2021-2026) & (K Units) Table 33. Global Spine Biologics Sales Share by Company (2021-2026) Table 34. Global Spine Biologics Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Spine Biologics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Spine Biologics Major Company Production Sites and Headquarters Table 37. Global Spine Biologics Company, Product Type & Application Table 38. Global Spine Biologics Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Spine Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Spine Biologics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Spine Biologics Sales by Region (2021-2026) & (K Units) Table 43. Global Spine Biologics Sales Market Share in Volume by Region (2021-2026) Table 44. Global Spine Biologics Sales by Region (2021-2026) & (US$ Million) Table 45. Global Spine Biologics Sales Market Share in Value by Region (2021-2026) Table 46. Global Spine Biologics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Spine Biologics Sales by Region (2027-2032) & (K Units) Table 48. Global Spine Biologics Sales Market Share in Volume by Region (2027-2032) Table 49. Global Spine Biologics Sales by Region (2027-2032) & (US$ Million) Table 50. Global Spine Biologics Sales Market Share in Value by Region (2027-2032) Table 51. Global Spine Biologics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Spine Biologics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Spine Biologics Sales by Application (2021-2026) & (K Units) Table 54. Global Spine Biologics Sales Market Share in Volume by Application (2021-2026) Table 55. Global Spine Biologics Sales by Application (2021-2026) & (US$ Million) Table 56. Global Spine Biologics Sales Market Share in Value by Application (2021-2026) Table 57. Global Spine Biologics Price by Application (2021-2026) & (USD/Unit) Table 58. Global Spine Biologics Sales by Application (2027-2032) & (K Units) Table 59. Global Spine Biologics Sales Market Share in Volume by Application (2027-2032) Table 60. Global Spine Biologics Sales by Application (2027-2032) & (US$ Million) Table 61. Global Spine Biologics Sales Market Share in Value by Application (2027-2032) Table 62. Global Spine Biologics Price by Application (2027-2032) & (USD/Unit) Table 63. North America Spine Biologics Sales by Application (2021-2026) & (K Units) Table 64. North America Spine Biologics Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Spine Biologics Sales by Application (2021-2026) & (K Units) Table 66. Europe Spine Biologics Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Spine Biologics Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Spine Biologics Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Spine Biologics Sales by Application (2021-2026) & (K Units) Table 70. Latin America Spine Biologics Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Spine Biologics Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Spine Biologics Sales by Application (2021-2026) & (US$ Million) Table 73. Medtronic Company Information Table 74. Medtronic Business Overview Table 75. Medtronic Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Medtronic Spine Biologics Product Portfolio Table 77. Medtronic Recent Development Table 78. Depuy Synthes Company Information Table 79. Depuy Synthes Business Overview Table 80. Depuy Synthes Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Depuy Synthes Spine Biologics Product Portfolio Table 82. Depuy Synthes Recent Development Table 83. Stryker Corporation Company Information Table 84. Stryker Corporation Business Overview Table 85. Stryker Corporation Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Stryker Corporation Spine Biologics Product Portfolio Table 87. Stryker Corporation Recent Development Table 88. Nuvasive Company Information Table 89. Nuvasive Business Overview Table 90. Nuvasive Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Nuvasive Spine Biologics Product Portfolio Table 92. Nuvasive Recent Development Table 93. Zimmer Biomet Company Information Table 94. Zimmer Biomet Business Overview Table 95. Zimmer Biomet Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Zimmer Biomet Spine Biologics Product Portfolio Table 97. Zimmer Biomet Recent Development Table 98. Orthofix International Company Information Table 99. Orthofix International Business Overview Table 100. Orthofix International Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Orthofix International Spine Biologics Product Portfolio Table 102. Orthofix International Recent Development Table 103. Globus Medical Company Information Table 104. Globus Medical Business Overview Table 105. Globus Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Globus Medical Spine Biologics Product Portfolio Table 107. Globus Medical Recent Development Table 108. alphatec spine Company Information Table 109. alphatec spine Business Overview Table 110. alphatec spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. alphatec spine Spine Biologics Product Portfolio Table 112. alphatec spine Recent Development Table 113. K2M Company Information Table 114. K2M Business Overview Table 115. K2M Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. K2M Spine Biologics Product Portfolio Table 117. K2M Recent Development Table 118. Exactech Company Information Table 119. Exactech Business Overview Table 120. Exactech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Exactech Spine Biologics Product Portfolio Table 122. Exactech Recent Development Table 123. Wright Medical Technology Company Information Table 124. Wright Medical Technology Business Overview Table 125. Wright Medical Technology Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Wright Medical Technology Spine Biologics Product Portfolio Table 127. Wright Medical Technology Recent Development Table 128. X-Spine Company Information Table 129. X-Spine Business Overview Table 130. X-Spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. X-Spine Spine Biologics Product Portfolio Table 132. X-Spine Recent Development Table 133. Nutech Company Information Table 134. Nutech Business Overview Table 135. Nutech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Nutech Spine Biologics Product Portfolio Table 137. Nutech Recent Development Table 138. Arthrex Company Information Table 139. Arthrex Business Overview Table 140. Arthrex Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. Arthrex Spine Biologics Product Portfolio Table 142. Arthrex Recent Development Table 143. North America Spine Biologics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. North America Spine Biologics Sales by Country (2021-2026) & (K Units) Table 145. North America Spine Biologics Sales Market Share by Country (2021-2026) Table 146. North America Spine Biologics Sales Forecast by Country (2027-2032) & (K Units) Table 147. North America Spine Biologics Sales Market Share Forecast by Country (2027-2032) Table 148. North America Spine Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Spine Biologics Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Spine Biologics Market Share by Country (2021-2026) Table 151. North America Spine Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Spine Biologics Market Share Forecast by Country (2027-2032) Table 153. Europe Spine Biologics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Europe Spine Biologics Sales by Country (2021-2026) & (K Units) Table 155. Europe Spine Biologics Sales Market Share by Country (2021-2026) Table 156. Europe Spine Biologics Sales Forecast by Country (2027-2032) & (K Units) Table 157. Europe Spine Biologics Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Spine Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Spine Biologics Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Spine Biologics Market Share by Country (2021-2026) Table 161. Europe Spine Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Spine Biologics Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Spine Biologics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Spine Biologics Sales by Country (2021-2026) & (K Units) Table 165. Asia-Pacific Spine Biologics Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Spine Biologics Sales Forecast by Country (2027-2032) & (K Units) Table 167. Asia-Pacific Spine Biologics Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Spine Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Spine Biologics Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Spine Biologics Market Share by Country (2021-2026) Table 171. Asia-Pacific Spine Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Spine Biologics Market Share Forecast by Country (2027-2032) Table 173. Latin America Spine Biologics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Latin America Spine Biologics Sales by Country (2021-2026) & (K Units) Table 175. Latin America Spine Biologics Sales Market Share by Country (2021-2026) Table 176. Latin America Spine Biologics Sales Forecast by Country (2027-2032) & (K Units) Table 177. Latin America Spine Biologics Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Spine Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Spine Biologics Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Spine Biologics Market Share by Country (2021-2026) Table 181. Latin America Spine Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Spine Biologics Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Spine Biologics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Spine Biologics Sales by Country (2021-2026) & (K Units) Table 185. Middle East and Africa Spine Biologics Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Spine Biologics Sales Forecast by Country (2027-2032) & (K Units) Table 187. Middle East and Africa Spine Biologics Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Spine Biologics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Spine Biologics Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Spine Biologics Market Share by Country (2021-2026) Table 191. Middle East and Africa Spine Biologics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Spine Biologics Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Spine Biologics Distributors List Table 196. Spine Biologics Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Spine Biologics Image Figure 2. Global Spine Biologics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spine Biologics Market Size (2021-2032) & (US$ Million) Figure 4. Global Spine Biologics Sales (2021-2032) & (K Units) Figure 5. Bone Graft Image Figure 6. Global Bone Graft Sales YoY Growth (2021-2032) & (K Units) Figure 7. Bone Graft Substitute Image Figure 8. Global Bone Graft Substitute Sales YoY Growth (2021-2032) & (K Units) Figure 9. Platelet Rich Plasma (PRP) Image Figure 10. Global Platelet Rich Plasma (PRP) Sales YoY Growth (2021-2032) & (K Units) Figure 11. BMAC (Bone Marrow Aspirate Concentrate) Image Figure 12. Global BMAC (Bone Marrow Aspirate Concentrate) Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Spine Biologics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Spine Biologics Market Share by Type 2025 VS 2032 Figure 15. North America Spine Biologics Sales Market Share in Volume by Type in 2025 Figure 16. North America Spine Biologics Sales Market Share in Value by Type in 2025 Figure 17. Europe Spine Biologics Sales Market Share in Volume by Type in 2025 Figure 18. Europe Spine Biologics Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Spine Biologics Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Spine Biologics Sales Market Share in Value by Type in 2025 Figure 21. Latin America Spine Biologics Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Spine Biologics Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Spine Biologics Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Spine Biologics Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Spine Biologics Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Anterior Cervical Discectomy and Fusion Image Figure 28. Global Anterior Cervical Discectomy and Fusion Sales YoY Growth (2021-2032) & (K Units) Figure 29. Posterior Lumbar Interbody Fusion Image Figure 30. Global Posterior Lumbar Interbody Fusion Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Spine Biologics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Spine Biologics Market Share by Application 2025 VS 2032 Figure 35. North America Spine Biologics Sales Market Share in Volume by Application in 2025 Figure 36. North America Spine Biologics Sales Market Share in Value by Application in 2025 Figure 37. Europe Spine Biologics Sales Market Share in Volume by Application in 2025 Figure 38. Europe Spine Biologics Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Spine Biologics Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Spine Biologics Sales Market Share in Value by Application in 2025 Figure 41. Latin America Spine Biologics Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Spine Biologics Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Spine Biologics Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Spine Biologics Sales Market Share in Value by Application in 2025 Figure 45. North America Spine Biologics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Spine Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Spine Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Spine Biologics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Spine Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Spine Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Spine Biologics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Spine Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Spine Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Spine Biologics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Spine Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Spine Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Spine Biologics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Spine Biologics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Spine Biologics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Spine Biologics Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Spine Biologics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Bone Graft
  • Bone Graft Substitute
  • Platelet Rich Plasma (PRP)
  • BMAC (Bone Marrow Aspirate Concentrate)
Applications
  • Anterior Cervical Discectomy and Fusion
  • Posterior Lumbar Interbody Fusion
  • Others
Companies covered
  • Medtronic
  • Depuy Synthes
  • Stryker Corporation
  • Nuvasive
  • Zimmer Biomet
  • Orthofix International
  • Globus Medical
  • alphatec spine
  • K2M
  • Exactech
  • Wright Medical Technology
  • X-Spine
  • Nutech
  • Arthrex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Spine Biologics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Spine Biologics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Spine Biologics Market by Type
  6. 1.3.1 Bone Graft
  7. 1.3.2 Bone Graft Substitute
  8. 1.3.3 Platelet Rich Plasma (PRP)
  9. 1.3.4 BMAC (Bone Marrow Aspirate Concentrate)
  10. 1.4 Global Spine Biologics Market Size by Type
  11. 1.4.1 Global Spine Biologics Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Spine Biologics Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Spine Biologics Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Spine Biologics Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Spine Biologics Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Spine Biologics Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Spine Biologics Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Spine Biologics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Spine Biologics Industry Trends
  2. 2.2 Spine Biologics Industry Drivers
  3. 2.3 Spine Biologics Industry Opportunities and Challenges
  4. 2.4 Spine Biologics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Spine Biologics Revenue (2021-2026)
  2. 3.2 Global Top Players by Spine Biologics Sales (2021-2026)
  3. 3.3 Global Top Players by Spine Biologics Price (2021-2026)
  4. 3.4 Global Spine Biologics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Spine Biologics Major Company Production Sites & Headquarters
  6. 3.6 Global Spine Biologics Company, Product Type & Application
  7. 3.7 Global Spine Biologics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Spine Biologics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Spine Biologics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Spine Biologics Tier 1, Tier 2, and Tier 3
4 Spine Biologics Regional Status and Outlook
  1. 4.1 Global Spine Biologics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Spine Biologics Historic Market Size by Region
  3. 4.2.1 Global Spine Biologics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Spine Biologics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Spine Biologics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Spine Biologics Forecasted Market Size by Region
  7. 4.3.1 Global Spine Biologics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Spine Biologics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Spine Biologics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Spine Biologics by Application
  1. 5.1 Spine Biologics Market by Application
  2. 5.1.1 Anterior Cervical Discectomy and Fusion
  3. 5.1.2 Posterior Lumbar Interbody Fusion
  4. 5.1.3 Others
  5. 5.2 Global Spine Biologics Market Size by Application
  6. 5.2.1 Global Spine Biologics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Spine Biologics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Spine Biologics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Spine Biologics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Spine Biologics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Spine Biologics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Spine Biologics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Spine Biologics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Medtronic Spine Biologics Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 Depuy Synthes
  8. 6.2.1 Depuy Synthes Company Information
  9. 6.2.2 Depuy Synthes Business Overview
  10. 6.2.3 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Depuy Synthes Spine Biologics Product Portfolio
  12. 6.2.5 Depuy Synthes Recent Developments
  13. 6.3 Stryker Corporation
  14. 6.3.1 Stryker Corporation Company Information
  15. 6.3.2 Stryker Corporation Business Overview
  16. 6.3.3 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Stryker Corporation Spine Biologics Product Portfolio
  18. 6.3.5 Stryker Corporation Recent Developments
  19. 6.4 Nuvasive
  20. 6.4.1 Nuvasive Company Information
  21. 6.4.2 Nuvasive Business Overview
  22. 6.4.3 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nuvasive Spine Biologics Product Portfolio
  24. 6.4.5 Nuvasive Recent Developments
  25. 6.5 Zimmer Biomet
  26. 6.5.1 Zimmer Biomet Company Information
  27. 6.5.2 Zimmer Biomet Business Overview
  28. 6.5.3 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zimmer Biomet Spine Biologics Product Portfolio
  30. 6.5.5 Zimmer Biomet Recent Developments
  31. 6.6 Orthofix International
  32. 6.6.1 Orthofix International Company Information
  33. 6.6.2 Orthofix International Business Overview
  34. 6.6.3 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Orthofix International Spine Biologics Product Portfolio
  36. 6.6.5 Orthofix International Recent Developments
  37. 6.7 Globus Medical
  38. 6.7.1 Globus Medical Company Information
  39. 6.7.2 Globus Medical Business Overview
  40. 6.7.3 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Globus Medical Spine Biologics Product Portfolio
  42. 6.7.5 Globus Medical Recent Developments
  43. 6.8 alphatec spine
  44. 6.8.1 alphatec spine Company Information
  45. 6.8.2 alphatec spine Business Overview
  46. 6.8.3 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 alphatec spine Spine Biologics Product Portfolio
  48. 6.8.5 alphatec spine Recent Developments
  49. 6.9 K2M
  50. 6.9.1 K2M Company Information
  51. 6.9.2 K2M Business Overview
  52. 6.9.3 K2M Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 K2M Spine Biologics Product Portfolio
  54. 6.9.5 K2M Recent Developments
  55. 6.10 Exactech
  56. 6.10.1 Exactech Company Information
  57. 6.10.2 Exactech Business Overview
  58. 6.10.3 Exactech Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Exactech Spine Biologics Product Portfolio
  60. 6.10.5 Exactech Recent Developments
  61. 6.11 Wright Medical Technology
  62. 6.11.1 Wright Medical Technology Company Information
  63. 6.11.2 Wright Medical Technology Business Overview
  64. 6.11.3 Wright Medical Technology Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Wright Medical Technology Spine Biologics Product Portfolio
  66. 6.11.5 Wright Medical Technology Recent Developments
  67. 6.12 X-Spine
  68. 6.12.1 X-Spine Company Information
  69. 6.12.2 X-Spine Business Overview
  70. 6.12.3 X-Spine Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 X-Spine Spine Biologics Product Portfolio
  72. 6.12.5 X-Spine Recent Developments
  73. 6.13 Nutech
  74. 6.13.1 Nutech Company Information
  75. 6.13.2 Nutech Business Overview
  76. 6.13.3 Nutech Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Nutech Spine Biologics Product Portfolio
  78. 6.13.5 Nutech Recent Developments
  79. 6.14 Arthrex
  80. 6.14.1 Arthrex Company Information
  81. 6.14.2 Arthrex Business Overview
  82. 6.14.3 Arthrex Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Arthrex Spine Biologics Product Portfolio
  84. 6.14.5 Arthrex Recent Developments
7 North America by Country
  1. 7.1 North America Spine Biologics Sales by Country
  2. 7.1.1 North America Spine Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Spine Biologics Sales by Country (2021-2026)
  4. 7.1.3 North America Spine Biologics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Spine Biologics Market Size by Country
  6. 7.2.1 North America Spine Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Spine Biologics Market Size by Country (2021-2026)
  8. 7.2.3 North America Spine Biologics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Spine Biologics Sales by Country
  2. 8.1.1 Europe Spine Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Spine Biologics Sales by Country (2021-2026)
  4. 8.1.3 Europe Spine Biologics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Spine Biologics Market Size by Country
  6. 8.2.1 Europe Spine Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Spine Biologics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Spine Biologics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Spine Biologics Sales by Country
  2. 9.1.1 Asia-Pacific Spine Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Spine Biologics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Spine Biologics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Spine Biologics Market Size by Country
  6. 9.2.1 Asia-Pacific Spine Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Spine Biologics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Spine Biologics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Spine Biologics Sales by Country
  2. 10.1.1 South America Spine Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Spine Biologics Sales by Country (2021-2026)
  4. 10.1.3 South America Spine Biologics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Spine Biologics Market Size by Country
  6. 10.2.1 South America Spine Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Spine Biologics Market Size by Country (2021-2026)
  8. 10.2.3 South America Spine Biologics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Spine Biologics Sales by Country
  2. 11.1.1 Middle East and Africa Spine Biologics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Spine Biologics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Spine Biologics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Spine Biologics Market Size by Country
  6. 11.2.1 Middle East and Africa Spine Biologics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Spine Biologics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Spine Biologics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Spine Biologics Value Chain Analysis
  2. 12.1.1 Spine Biologics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Spine Biologics Production Mode & Process
  7. 12.2 Spine Biologics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Spine Biologics Distributors
  10. 12.2.3 Spine Biologics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst